Last week we explored how the concepts we’ve been discussing in our series line up with FMEA/FMECA methodologies. This week, we’ll explore the two impostors, uncertainty and detectability risk, a little bit further.
Harness your expertise
See how QbDVision can help you leverage your team’s know-how to accelerate drug development.
GET OUR NEWSLETTER
CONTACT US
QbDVision, Inc.
2301 West Anderson Lane
Suite 101
Austin, TX, 78757
© 2017-2023 QbDVision. Privacy policy.
We use cookies and similar technologies to enable services and functionality on our site and to understand your interaction with our service. By clicking on accept, you agree to our use of such technologies for marketing and analytics.